| 0 (0%) | 11-30 07:29 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 196.41 | 1-year : | 229.41 |
| Resists | First : | 168.16 | Second : | 196.41 |
| Pivot price | 139.77  |
|||
| Supports | First : | 131.53 | Second : | 108.9 |
| MAs | MA(5) : | 157.41 |
MA(20) : | 135.04 |
| MA(100) : | 93.56 |
MA(250) : | 81.83 |
|
| MACD | MACD : | 12.1 |
Signal : | 9.1 |
| %K %D | K(14,3) : | 97.5  |
D(3) : | 96.8 |
| RSI | RSI(14): 77 |
|||
| 52-week | High : | 168.16 | Low : | 32.54 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ LABU ] has closed below upper band by 3.6%. Bollinger Bands are 175.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 168.18 - 168.77 | 168.77 - 169.3 |
| Low: | 156.4 - 157.13 | 157.13 - 157.8 |
| Close: | 164.31 - 165.36 | 165.36 - 166.32 |
Thu, 27 Nov 2025
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared - Stocktwits
Thu, 27 Nov 2025
LABU surges to 20-month high after softer Medicare cuts | Tap to know more | Inshorts - Inshorts
Fri, 21 Nov 2025
Avoiding Lag: Real-Time Signals in (LABU) Movement - news.stocktradersdaily.com
Thu, 14 Aug 2025
Labu’tique Pop-Up Shop | San Diego Padres - MLB.com
Wed, 06 Aug 2025
Labu-who? Chopard Teams Up With Dimoo of Pop Mart for Qixi Exclusive - Yahoo Finance
Wed, 06 Aug 2025
Labu-who? Chopard Teams Up With Dimoo of Pop Mart for Qixi Exclusive - WWD
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|